Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling

Biology of Blood and Marrow Transplantation

Volumn 23, Issue 3, 2017, Pages 529-532

  Johnpulle, Romany A N ^a   Paczesny, Sophie ^b   Jung, Dae Kwang ^a   Daguindau, Etienne ^b   Jagasia, Madan H ^a   Savani, Bipin N ^a   Chinratanalab, Wichai ^a   Cornell, Robert F ^a   Goodman, Stacey ^a   Greer, John P ^a   Kassim, Adetola A ^a   Sengsayadeth, Salyka ^a   Byrne, Michael T ^a   Engelhardt, Brian G ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic; IL 33; Metabolic complications; Post transplantation diabetes mellitus; Soluble suppression of tumorigenicity 2; sST2; Treatment related mortality

Indexed keywords

CALCINEURIN INHIBITOR; INTERLEUKIN 33; INTERLEUKIN RECEPTOR; METHOTREXATE; MYCOPHENOLATE MOFETIL; SUPPRESSION OF TUMORIGENICITY 2 RECEPTOR; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOIMMUNITY; ARTICLE; CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TUMOR ENGRAFTMENT; ALLOTRANSPLANTATION; BLOOD; GLUCOSE BLOOD LEVEL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 85009815216     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2016.12.627     Document Type: Article

References (14)

1. 1 Engelhardt, B.G., Jagasia, S.M., Crowe, J.E. Jr, et al. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood 119 (2012), 2417–2421.
2. 2 Griffith, M.L., Jagasia, M.H., Misfeldt, A.A., et al. Pretransplantation c-peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 17 (2011), 86–92.
3. 3 Sorror, M.L., Maris, M.B., Storb, R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005), 2912–2919.
4. 4 Rowlings, P.A., Przepiorka, D., Klein, J.P., et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 97 (1997), 855–864.
5. 5 Vasanthakumar, A., Moro, K., Xin, A., et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cell. Nat Immunol 16 (2015), 276–285.
6. 6 Reichenbach, D.K., Schwarze, V., Matta, B.M., et al. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. Blood 125 (2015), 3183–3192.
7. 7 Vander Lugt, M.T., Braun, T.M., Hanash, S., et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med 369 (2013), 529–539.
8. 8 Zhang, J., Ramadan, A.M., Griesenauer, B., et al. ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease. Sci Transl Med, 7, 2015, 308ra160.
9. 9 Feuerer, M., Herrero, L., Cipolletta, D., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15 (2009), 930–939.
10. 10 Winer, S., Chan, Y., Paltser, G., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15 (2009), 921–929.
11. reg cells prevents age-associated insulin resistance. Nature 528 (2015), 137–141.
12. 12 Przepiorka, D., Weisdorf, D., Martin, P., et al. 1994 Consensus conference on acute GVHD Grading. Bone Marrow Transplant 15 (1995), 825–828.
13. 13 Ponce, D.M., Hilden, P., Mumaw, C., et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood 125 (2015), 199–205.
14. 14 Maclver, N.J., Jacobs, S.R., Wieman, H.L., et al. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84 (2008), 949–957.